The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

  ()
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. read more >

Abbott Labs Launches Point-of-Care Diagnostic Tool that Can Detect COVID-19 in 5 Minutes

  ()
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOW™ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day. read more >
News Update

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

  ()
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. read more >

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

  ()
Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. read more >

Blockchain Holdings Acquires COVID-19 Quarantine Tracker Already in Use in Hong Kong

  ()
The company anticipates adoption of the TRACEsafe system by other countries soon. read more >

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment

  ()
Shares of Bellerophon Therapeutics traded more than 400% higher after the firm reported that the U.S. FDA granted emergency expanded access for its INOpulse® nitric oxide delivery system device for use in treatment of COVID-19 virus. read more >

OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility

  ()
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast. read more >

Predictive Oncology Launches AI Vaccine and Drug Platform & Acquires Technology

  ()
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology. read more >
News Update

Surgical Imaging Firm Reports Positive Physician Response to Bladder Cancer Visualization System

News Update
  ()
Imagin Medical announced on-going research feedback on its i/Blue™ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures. read more >

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

  ()
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. read more >

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test

  ()
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. read more >

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing

  ()
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. read more >

GenMark Shares Trade 30% Higher on Yearly Earnings and Increased SARS-CoV-2 Virus Detection Test Kit Shipments

  ()
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus. read more >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor

  ()
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. read more >
News Update

Tech Firm Announces New Deals Worth $1 Million

News Update
  ()
These newly signed contracts of HealthSpace Data Systems are with governmental agencies in two U.S. states. read more >

The 'Virus' Technology That Kills Coronavirus Plus Lots of Other Pathogens

Contributed Opinion
  ()
Fincom Investment Partners profiles TOMI Environmental Solutions, whose SteraMist disinfectant technology kills the coronavirus. read more >

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change

  ()
Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO. read more >

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance

  ()
Shares of Accuray Inc. traded 15% higher today after the company reported Q2/20 financial results. read more >

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test

  ()
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform. read more >

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Contributed Opinion
  ()
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. read more >

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery

  ()
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' read more >

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery

  ()
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. read more >

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications

  ()
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications. read more >
News Update

Developer Completes Design Verification of Imaging Device for Bladder Cancer

News Update
  ()
In doing so, it gets one step closer to market approval from U.S. regulators. read more >

Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System

  ()
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures. read more >
Showing Results: 1 to 25 of 32 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe